The European Prevention of Alzheimer's Dementia Consortium (EPAD) is a unique and ground-breaking European initiative to streamline the testing and development of preventative treatments for Alzheimer’s disease. Image The largest ever public-private partnership in Alzheimer’s disease research, EPAD combines knowledge and expertise from 39 organisations across multiple sectors. Together, we are developing a platform on which new compounds can be tested in a streamlined and efficient way, delivering more effective, targeted interventions that can slow or stop dementia. Currently Recruiting: No Visit the EPAD website Data Access Learn more about requesting access to EPAD data for your research This article was published on 2024-06-04
